Case counts going up in surge areas, while signs of tapering in places with wide use of masks and high rates of vaccinations.
Moderna awaits FDA approval; J&J provides more data, and those booster shots may be available sooner than eight months
Moderna awaits FDA approval; J&J provides…
Moderna awaits FDA approval; J&J provides more data, and those booster shots may be available sooner than eight months
Case counts going up in surge areas, while signs of tapering in places with wide use of masks and high rates of vaccinations.